(Q38383521)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25788425%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

review article

1 reference

title

Inflammation and prostate cancer: friends or foe? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25788425%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25788425%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Elena Monica Borroni

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25788425%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Gianluigi Taverna

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25788425%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Elisa Pedretti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25788425%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Giuseppe Di Caro

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25788425%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Fabio Grizzi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25788425%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

publication date

19 March 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25788425%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

published in

Inflammation Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25788425%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25788425%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

275-286

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25788425%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25788425%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00011-015-0812-2

3 March 2020

exact match

0 references

cites work

Evaluation of the current prostate cancer staging system based on cancer-specific mortality in the surveillance, epidemiology, and end results database

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

21 January 2018

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Prostate-specific antigen in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Exclusion of inflammation in the differential diagnosis of an elevated prostate-specific antigen (PSA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Screening and prostate-cancer mortality in a randomized European study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Prostate biopsy strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Random biopsy: when, how many and where to take the cores?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Targeted therapy of cancer: new roles for pathologists--prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Metabolomic signatures of aggressive prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

The development of nomograms for stratification of men at risk of prostate cancer prior to prostate biopsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Novel tools for prostate cancer prognosis, diagnosis, and follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Current early diagnostic biomarkers of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Prostate cancer overdiagnosis and overtreatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Role of inflammasomes and their regulators in prostate cancer initiation, progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

The link between benign prostatic hyperplasia and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Inflammation and prostate carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Senescent remodeling of the innate and adaptive immune system in the elderly men with prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Inflammation in prostate carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

B-cell-derived lymphotoxin promotes castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Does the microenvironment influence the cell types of origin for prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

The role of inflammation in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

The dark side of mast cell-targeted therapy in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Mast cells as a potential prognostic marker in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Identification and characterization of a tumor infiltrating CD56(+)/CD16 (-) NK cell subset with specificity for pancreatic and prostate cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Inflammation and preneoplastic lesions in benign prostate as risk factors for prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Prostate cancer and inflammation: the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Intratumoral T but not B lymphocytes are related to clinical outcome in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Immune system: a double-edged sword in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Macrophages, innate immunity and cancer: balance, tolerance, and diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Macrophage polarization in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

The role of M1 and M2 macrophages in prostate cancer in relation to extracapsular tumor extension and biochemical recurrence after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Immunohistochemical analysis of inflammatory cells in benign and precancerous lesions and carcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Down-regulation of macrophage inhibitory cytokine-1/prostate derived factor in benign prostatic hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

The roles of TGFβ in the tumour microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Growth/differentiation factor-15: prostate cancer suppressor or promoter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Role of natural killer and Gamma-delta T cells in West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Destructive impact of T-lymphocytes, NK and Mast cells on basal cell layers: implications for tumor invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Neutrophils in innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Low serum neutrophil count predicts a positive prostate biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Pretreatment neutrophil-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with ketoconazole: association with outcome and predictive nomogram

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Tumor immunology and cancer immunotherapy: summary of the 2013 SITC primer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

The relationship between T-lymphocyte subset infiltration and survival in patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

B7-H3 over expression in prostate cancer promotes tumor cell progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Analysis of circulating regulatory T cells (CD4+CD25+CD127-) after cryosurgery in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

CD4+CD25high T cells are enriched in the tumor and peripheral blood of prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Enhanced functionality of CD4+CD25(high)FoxP3+ regulatory T cells in the peripheral blood of patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

CD4 helper T cells, CD8 cytotoxic T cells, and FOXP3(+) regulatory T cells with respect to lethal prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Emerging roles of chemokines in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

The chemokine system and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Molecular link mechanisms between inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Chemokines and chemokine receptors as promoters of prostate cancer growth and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Innate and adaptive immune cells in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Chemokines and chemokine receptors: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

The chemokine system in cancer biology and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Chemokines in cancer related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Organ selectivity in metastasis: regulation by chemokines and their receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Homeostatic chemokine receptors and organ-specific metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Anterograde trafficking of CXCR4 and CCR2 receptors in a prostate cancer cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

CCR1/CCL5 interaction promotes invasion of taxane-resistant PC3 prostate cancer cells by increasing secretion of MMPs 2/9 and by activating ERK and Rac signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Detection of CXCR2 cytokine receptor surface expression using immunofluorescence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

The effect of CCL19/CCR7 on the proliferation and migration of cell in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Impact of CXCL1 overexpression on growth and invasion of prostate cancer cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

CCL2 increases αvβ3 integrin expression and subsequently promotes prostate cancer migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Infiltrating macrophages promote prostate tumorigenesis via modulating androgen receptor-mediated CCL4-STAT3 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Tissue injury and hypoxia promote malignant progression of prostate cancer by inducing CXCL13 expression in tumor myofibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

The IL-8-regulated chemokine receptor CXCR7 stimulates EGFR signaling to promote prostate cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

A pro-tumourigenic loop at the human prostate tumour interface orchestrated by oestrogen, CXCL12 and mast cell recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Androgen receptor, ccl2, and epithelial-mesenchymal transition: A dangerous affair in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

1alpha, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Current status of biomarkers for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Biology of prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Biomarkers for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

CCL2 Chemokine as a Potential Biomarker for Prostate Cancer: A Pilot Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

CCL11 (eotaxin-1): a new diagnostic serum marker for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Chemokine (C-X-C motif) ligand 1 (CXCL1) protein expression is increased in high-grade prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Human prostate cancer risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Tumor immunobiological differences in prostate cancer between African-American and European-American men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Association between SDF1-3'A or CXCR4 gene polymorphisms with predisposition to and clinicopathological characteristics of prostate cancer with or without metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Inhibition of CCL2 signaling in combination with docetaxel treatment has profound inhibitory effects on prostate cancer growth in bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Targeting chemokine (C-C motif) ligand 2 (CCL2) as an example of translation of cancer molecular biology to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Design, syntheses, and characterization of piperazine based chemokine receptor CCR5 antagonists as anti prostate cancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Design, syntheses, and characterization of pharmacophore based chemokine receptor CCR5 antagonists as anti prostate cancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

CXCL12/CXCR4 signaling counteracts docetaxel-induced microtubule stabilization via p21-activated kinase 4-dependent activation of LIM domain kinase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

CXCR4 and PTEN are involved in the anti-metastatic regulation of anethole in DU145 prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Intratumour heterogeneity in urologic cancers: from molecular evidence to clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Genetic predisposition to prostate cancer: Update and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Targeting the tumor stroma as a novel therapeutic approach for prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Development of animal models underlining mechanistic connections between prostate inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Clinical evaluation of systemic and local immune responses in cancer: time for integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

The immune contexture in human tumours: impact on clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Prostate cancer: intriguing data on inflammation and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Presence of prostate cancer metastasis correlates with lower lymph node reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0812-2

Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial

21 January 2018

1 reference

12 December 2020

Recent trends in Gleason grading of prostate cancer: I. Pattern interpretation.

1 reference

12 December 2020

Prostate cancer epigenetic biomarkers: next-generation technologies.

1 reference

12 December 2020

Correlation of histological inflammation in needle biopsy specimens with serum prostate- specific antigen levels in men with negative biopsy for prostate cancer

1 reference

12 December 2020

IL-17 Expression by macrophages is associated with proliferative inflammatory atrophy lesions in prostate cancer patients

1 reference

12 December 2020

Tumor microenvironment and metabolism in prostate cancer

1 reference

12 December 2020

Contemporary update on pathology-related issues on routine workup of prostate biopsy: sectioning, tumor extent measurement, specimen orientation, and immunohistochemistry

1 reference

12 December 2020

Genetic variants of chemokine CCL2 and chemokine receptor CCR2 genes and risk of prostate cancer

1 reference

12 December 2020

A single injection of lidocaine as local anesthesia for ultrasound guided needle biopsy of the prostate

1 reference

12 December 2020

1 reference

12 December 2020

Phenotypic characterization of the infiltrating immune cells in normal prostate, benign nodular prostatic hyperplasia and prostatic adenocarcinoma

1 reference

12 December 2020

Mast cell phenotype in benign and malignant tumors of the prostate.

1 reference

12 December 2020

Leukocytic promotion of prostate cellular proliferation

1 reference

12 December 2020

Molecular biology underlying the clinical heterogeneity of prostate cancer: an update

1 reference

12 December 2020

Interactions between normal human fibroblasts and human prostate cancer cells in a co-culture system

1 reference

12 December 2020

An evolutionary perspective on anti-tumor immunity

1 reference

12 December 2020

Dendritic and lymphocytic cell infiltration in prostate carcinoma.

1 reference

12 December 2020

CC chemokine ligand 18 correlates with malignant progression of prostate cancer.

1 reference

12 December 2020

Eotaxin-1 promotes prostate cancer cell invasion via activation of the CCR3-ERK pathway and upregulation of MMP-3 expression

1 reference

12 December 2020

Elevated IL-8, TNF-α, and MCP-1 in men with metastatic prostate cancer starting androgen-deprivation therapy (ADT) are associated with shorter time to castration-resistance and overall survival

1 reference

12 December 2020

CXCL8, an underestimated "bad guy" in prostate cancer

1 reference

12 December 2020

Inflammation-associated regulation of the macrophage inhibitory cytokine (MIC-1) gene in prostate cancer

1 reference

12 December 2020

CC chemokine ligand 18 and IGF-binding protein 6 as potential serum biomarkers for prostate cancer

1 reference

12 December 2020